GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Total Current Liabilities

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Total Current Liabilities : ฿209.46 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. JSP Pharmaceutical Manufacturing (Thailand) PCL's total current liabilities for the quarter that ended in Mar. 2024 was ฿209.46

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Current Liabilities Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Current Liabilities Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
203.12 181.04 114.61 142.00 194.80

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.91 142.38 200.54 194.80 209.46

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=75.047+108.595
+Other Current Liabilities+Current Deferred Liabilities
=0+11.156
=194.80

JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Current Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=87.448+100.442
+Other Current Liabilities+Current Deferred Liabilities
=2.8421709430404E-14+21.565
=209.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Total Current Liabilities
Comparable Companies
BKK:DOD BKK:SSF BKK:NV BKK:SFP BKK:JDF BKK:LEE BKK:BIS BKK:TC BKK:SST BKK:CFRESH XSWX:NESN SHSE:603288 KHC GIS XPAR:BN SHSE:600887 SZSE:300999 HRL MKC K
Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
Website
https://www.jsppharma.com
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines